Evidence map›Paper›PMID 35506115›Full record

ArticleBiocybernetics and biomedical engineering

TL-med: A Two-stage transfer learning recognition model for medical images of COVID-19.

Jiana Meng, Zhiyong Tan, Yuhai Yu, Pengjie Wang, Shuang Liu

Abstract read
In one paragraph

Article in Biocybernetics and biomedical engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. TransSensors (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiana MengSchool of Computer Science and Engineering, Dalian Minzu University, Dalian, Liaoning 116600, China.
Zhiyong TanSchool of Computer Science and Engineering, Dalian Minzu University, Dalian, Liaoning 116600, China.
Yuhai YuSchool of Computer Science and Engineering, Dalian Minzu University, Dalian, Liaoning 116600, China.
Pengjie WangSchool of Computer Science and Engineering, Dalian Minzu University, Dalian, Liaoning 116600, China.
Shuang LiuSchool of Computer Science and Engineering, Dalian Minzu University, Dalian, Liaoning 116600, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recognition of medical images with deep learning techniques can assist physicians in clinical diagnosis, but the effectiveness of recognition models relies on massive amounts of labeled data. With the rampant development of the novel coronavirus (COVID-19) worldwide, rapid COVID-19 diagnosis has become an effective measure to combat the outbreak. However, labeled COVID-19 data are scarce. Therefore, we propose a two-stage transfer learning recognition model for medical images of COVID-19 (TL-Med) based on the concept of "generic domain-target-related domain-target domain". First, we use the Vision Transformer (ViT) pretraining model to obtain generic features from massive heterogeneous data and then learn medical features from large-scale homogeneous data. Two-stage transfer learning uses the learned primary features and the underlying information for COVID-19 image recognition to solve the problem by which data insufficiency leads to the inability of the model to learn underlying target dataset information. The experimental results obtained on a COVID-19 dataset using the TL-Med model produce a recognition accuracy of 93.24%, which shows that the proposed method is more effective in detecting COVID-19 images than other approaches and may greatly alleviate the problem of data scarcity in this field.

Indexed as

COVID-19Pretrained ModelTransfer LearningViT

Identifiers

PMID35506115
PMCPMC9051950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.